Ningbo Historical Income Statement

300439 Stock

11.43 0.05 0.44%

Historical analysis of Ningbo MedicalSystem income statement accounts such as Selling General Administrative of 307.3 M, Total Revenue of 1.8 B or Operating Income of 283.2 M can show how well Ningbo MedicalSystem Biotechnology performed in making a profits. Evaluating Ningbo MedicalSystem income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Ningbo MedicalSystem's future profits or losses.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Ningbo MedicalSystem latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Ningbo MedicalSystem is a good buy for the upcoming year.

Net Income Gross Profit

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Ningbo MedicalSystem Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

About Ningbo Income Statement Analysis

Ningbo MedicalSystem Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Ningbo MedicalSystem shareholders. The income statement also shows Ningbo investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Ningbo MedicalSystem Income Statement Chart

At present, Ningbo MedicalSystem's Operating Income is projected to increase significantly based on the last few years of reporting. The current year's Cost Of Revenue is expected to grow to about 1.1 B, whereas Interest Expense is forecasted to decline to about 10.1 M.

Selling General Administrative Total Revenue Operating Income Cost Of Revenue Ebitda

Total Revenue

Total revenue comprises all receipts Ningbo MedicalSystem generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Operating Income

Operating Income is the amount of profit realized from Ningbo MedicalSystem operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Ningbo MedicalSystem Biotechnology is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.

Cost Of Revenue

Cost of Revenue is found on Ningbo MedicalSystem income statement and represents the costs associated with goods and services Ningbo MedicalSystem provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Most accounts from Ningbo MedicalSystem's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Ningbo MedicalSystem current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Ningbo MedicalSystem Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

	2021	2022	2023	2024 (projected)
Operating Income	295.9M	312.8M	253.0M	283.2M
Total Revenue	2.3B	2.5B	1.9B	1.8B

Operating Income Total Revenue

Ningbo MedicalSystem income statement Correlations

	Selling General Administrative	Total Revenue	Operating Income	Cost Of Revenue	Income Before Tax	Net Income	Income Tax Expense	Research Development	Gross Profit	Other Operating Expenses	Net Income From Continuing Ops	Ebit	Total Operating Expenses	Total Other Income Expense Net	Minority Interest	Tax Provision	Net Interest Income	Interest Income	Ebitda	Reconciled Depreciation
Selling General Administrative		0.95	0.87	0.94	-0.04	-0.09	0.45	0.85	0.92	0.67	-0.21	0.65	0.93	-0.52	0.3	0.33	-0.62	0.34	-0.32	0.8
Total Revenue	0.95		0.96	1.0	-0.11	-0.18	0.51	0.82	0.98	0.57	-0.28	0.78	0.99	-0.61	0.42	0.42	-0.69	0.3	-0.39	0.78
Operating Income	0.87	0.96		0.94	-0.03	-0.12	0.67	0.73	0.95	0.37	-0.22	0.89	0.93	-0.77	0.63	0.56	-0.69	0.22	-0.31	0.62
Cost Of Revenue	0.94	1.0	0.94		-0.15	-0.22	0.51	0.79	0.97	0.58	-0.31	0.76	0.99	-0.59	0.41	0.43	-0.73	0.27	-0.41	0.77
Income Before Tax	-0.04	-0.11	-0.03	-0.15		0.99	0.11	0.1	-0.07	0.1	0.98	0.07	-0.15	-0.26	0.25	0.09	0.33	0.2	0.95	0.03
Net Income	-0.09	-0.18	-0.12	-0.22	0.99		0.02	0.07	-0.14	0.1	0.99	-0.02	-0.21	-0.17	0.16	0.0	0.41	0.21	0.96	0.01
Income Tax Expense	0.45	0.51	0.67	0.51	0.11	0.02		0.15	0.47	-0.04	-0.04	0.86	0.45	-0.87	0.94	0.9	-0.75	-0.4	-0.02	-0.07
Research Development	0.85	0.82	0.73	0.79	0.1	0.07	0.15		0.83	0.64	-0.05	0.54	0.79	-0.31	0.1	-0.02	-0.24	0.57	-0.2	0.84
Gross Profit	0.92	0.98	0.95	0.97	-0.07	-0.14	0.47	0.83		0.53	-0.24	0.78	0.99	-0.64	0.42	0.38	-0.59	0.42	-0.36	0.8
Other Operating Expenses	0.67	0.57	0.37	0.58	0.1	0.1	-0.04	0.64	0.53		0.02	0.13	0.59	0.07	-0.22	0.02	-0.33	0.39	-0.05	0.74
Net Income From Continuing Ops	-0.21	-0.28	-0.22	-0.31	0.98	0.99	-0.04	-0.05	-0.24	0.02		-0.1	-0.31	-0.12	0.12	-0.03	0.46	0.16	0.98	-0.07
Ebit	0.65	0.78	0.89	0.76	0.07	-0.02	0.86	0.54	0.78	0.13	-0.1		0.73	-0.87	0.86	0.7	-0.66	-0.03	-0.16	0.3
Total Operating Expenses	0.93	0.99	0.93	0.99	-0.15	-0.21	0.45	0.79	0.99	0.59	-0.31	0.73		-0.58	0.37	0.39	-0.67	0.36	-0.41	0.81
Total Other Income Expense Net	-0.52	-0.61	-0.77	-0.59	-0.26	-0.17	-0.87	-0.31	-0.64	0.07	-0.12	-0.87	-0.58		-0.93	-0.77	0.54	0.02	-0.07	-0.19
Minority Interest	0.3	0.42	0.63	0.41	0.25	0.16	0.94	0.1	0.42	-0.22	0.12	0.86	0.37	-0.93		0.86	-0.56	-0.29	0.12	-0.12
Tax Provision	0.33	0.42	0.56	0.43	0.09	0.0	0.9	-0.02	0.38	0.02	-0.03	0.7	0.39	-0.77	0.86		-0.76	-0.34	0.02	-0.12
Net Interest Income	-0.62	-0.69	-0.69	-0.73	0.33	0.41	-0.75	-0.24	-0.59	-0.33	0.46	-0.66	-0.67	0.54	-0.56	-0.76		0.39	0.43	-0.22
Interest Income	0.34	0.3	0.22	0.27	0.2	0.21	-0.4	0.57	0.42	0.39	0.16	-0.03	0.36	0.02	-0.29	-0.34	0.39		0.03	0.69
Ebitda	-0.32	-0.39	-0.31	-0.41	0.95	0.96	-0.02	-0.2	-0.36	-0.05	0.98	-0.16	-0.41	-0.07	0.12	0.02	0.43	0.03		-0.21
Reconciled Depreciation	0.8	0.78	0.62	0.77	0.03	0.01	-0.07	0.84	0.8	0.74	-0.07	0.3	0.81	-0.19	-0.12	-0.12	-0.22	0.69	-0.21

Click cells to compare fundamentals

Ningbo MedicalSystem Account Relationship Matchups

Ningbo MedicalSystem income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Interest Expense	81.4M	55.1M	29.3M	15.6M	10.7M	10.1M
Selling General Administrative	441.3M	462.1M	351.7M	364.7M	328.6M	307.3M
Total Revenue	3.1B	2.3B	2.3B	2.5B	1.9B	1.8B
Operating Income	377.0M	268.6M	295.9M	312.8M	253.0M	283.2M
Cost Of Revenue	2.1B	1.5B	1.3B	1.5B	1.0B	1.1B
Income Before Tax	(525.1M)	347.0M	218.2M	223.3M	295.7M	184.2M
Net Income Applicable To Common Shares	(559.9M)	299.5M	179.5M	198.5M	178.7M	91.6M
Net Income	(559.9M)	299.5M	179.5M	198.5M	256.6M	137.3M
Income Tax Expense	51.6M	53.5M	28.1M	18.1M	20.8M	19.8M
Research Development	128.3M	135.5M	150.7M	171.8M	149.8M	128.8M
Gross Profit	1.1B	848.3M	911.3M	949.6M	841.2M	920.1M
Other Operating Expenses	10.2M	17.9M	10.6M	10.2M	11.7M	10.6M
Net Income From Continuing Ops	(576.6M)	293.6M	190.2M	205.2M	259.5M	145.0M
Ebit	324.6M	265.7M	266.7M	264.6M	238.1M	243.4M
Total Operating Expenses	2.8B	2.0B	2.0B	2.2B	1.6B	2.0B
Minority Interest	51.1M	45.3M	(10.7M)	(6.7M)	(2.9M)	(2.8M)
Tax Provision	51.6M	53.5M	28.1M	18.1M	36.2M	38.0M
Net Interest Income	(80.1M)	(53.5M)	(23.2M)	(9.2M)	2.4M	2.5M
Interest Income	1.9M	2.6M	6.7M	7.5M	13.3M	13.9M
Ebitda	(282.2M)	575.7M	442.3M	430.6M	495.2M	408.1M
Reconciled Depreciation	161.5M	173.5M	194.8M	191.7M	169.6M	180.8M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ESRT	Empire State Realty
C	Citigroup
C	Citigroup

Other Information on Investing in Ningbo Stock

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Ningbo Historical Income Statement

About Ningbo Income Statement Analysis

Ningbo MedicalSystem Income Statement Chart

Total Revenue

Operating Income

Cost Of Revenue

Ningbo MedicalSystem income statement Correlations

Ningbo MedicalSystem Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Ningbo MedicalSystem income statement Accounts

Also Currently Popular

Other Information on Investing in Ningbo Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cost Of Revenue	+ 1.0	Total Revenue
Total Operating Expenses	+ 0.99	Total Revenue
Total Operating Expenses	+ 0.99	Cost Of Revenue
Net Income	+ 0.99	Income Before Tax
Net Income From Continuing Ops	+ 0.99	Net Income
Total Operating Expenses	+ 0.99	Gross Profit

Minority Interest	- 0.93	Total Other Income Expense Net
Total Other Income Expense Net	- 0.87	Ebit
Total Other Income Expense Net	- 0.87	Income Tax Expense
Tax Provision	- 0.77	Total Other Income Expense Net
Total Other Income Expense Net	- 0.77	Operating Income
Net Interest Income	- 0.76	Tax Provision